版本:
中国

BRIEF-Endo says reviewing FDA's request to withdraw Opana ER from market

June 8 Endo International Plc:

* Endo response to june 8, 2017 FDA meeting related to opana® er

* Endo international plc- "endo is reviewing request and is evaluating full range of potential options as we determine appropriate path forward"

* Endo - fda's request to withdraw opana er from market does not indicate uncertainty with product's safety or efficacy when taken as prescribed Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐